Global Diabetic Injection Pen Market By Type (Insulin Pens and Pen Needles), By Usage (Disposable Injection Pens and Reusable Injection Pens); By Therapy (Diabetes, Growth Hormone Therapy, Fertility, Osteoporosis, and Others), and By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Medical Stores, and Diabetes Clinics), Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2019-2026

Market Definition

Global Diabetic Injection Pen market is estimated to reach $33.29 Billion by 2026; growing at a CAGR of 5.12% from 2019 to 2026.

A diabetic injection pen is a portable device that is used to administer insulin – a vital hormone for people who have diabetes. This pen contains a cartridge, a dial to measure dosage, and a disposable needle to deliver the dose. These pens come in two basic forms – disposable and reusable. Diabetic injection pens are easy to use and can be injected anywhere as they are portable and lightweight. In addition, these pens are capable to adjust the dose as per the patient's need. These pens are growing in popularity owing to the easy, accurate and convenient delivery of insulin, which is one of the major factors driving the growth of the global diabetic injection market.

Market Determinants

The global diabetic injection pen market is primarily driven by the growing prevalence of diabetes. For instance, according to the National Diabetes Statistics report 2017, around 30.3 million people have diabetes and 23.1 million among them were diagnosed by diabetes. In addition, managing diabetes requires a daily dosage of insulin that also drives the global market growth. Some other factors such as the growing consumption of unhealthy food, changing lifestyles, and raising awareness for diabetes treatment also boost market growth.

However, a threat from alternate drug delivery modes such as tablets and insulin patches could hamper the market from growing. Then again, consumer's opinions to avoid usage of such devices especially in emerging economies may also hinder the market growth. Moreover, technological advancements along with rising R&D activities among insulin administration is likely to witness strong growth throughout the forecast period. Further, growing product approvals for diabetes injection pen by healthcare authorities encourages the market to grow significantly in the coming years.

Market Segmentation

The global diabetic injection pen market is mainly classified based on type, usage, therapy, and distribution channel. Based on the type segment, the market is categorized into insulin pens and pen needles. The usage segment can be fabricated into reusable injection pens and disposable injection pens. Therapy is further segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and others. On the basis of the distribution channel, the market is further categorized into hospital pharmacies, retail pharmacies, online medical stores, and diabetes clinics. 

Regional Analysis

Based on geography, the global Diabetic Injection Pen market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Among all the regions, North America accounts for the majority of the share in the year 2018 and is likely to continue its trend throughout the forecast period. The high growth in the region is owing to the rising number of cases of diabetes in the U.S., and growing R&D activities for the development of advanced injection pens by the leading player in the region. However, APAC is the fastest-growing region with respect to CAGR during the forecast period from 2019 to 2026, owing to the rising elderly population, rising awareness among the population, and improving healthcare infrastructure in countries such as China, Japan, and India.

Market Leaders

Key players operating in the Diabetic Injection Pen industry include AstraZeneca Plc, Becton, Dickinson and Company, Biocon, Eli Lilly and Company, Hoffmann-La Roche AG, Jiangsu Delfu medical device Co., Ltd., Merck & Company, Inc., and Novo Nordisk A/S, Sanofi SA, and Wockhardt Ltd. among others.

Diabetic Injection Pen Market Key Segments:

By Type

• Insulin Pens
• Pen Needles

By Usage

• Disposable Injection Pens
• Reusable Injection Pens

By Therapy

• Diabetes
• Growth Hormone Therapy
• Fertility
• Osteoporosis
• Others

By Distribution channel

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics
• Others

By Geography

• North America
• The U.S.
• Canada
• Mexico
• Europe
• U.K
• Germany
• France
• Italy
• Rest of Europe
• Asia Pacific
• India
• China
• Japan
• South Korea
• Rest of Asia Pacific
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• GCC Countries
• Egypt
• South Africa
• Rest of Middle East & Africa

Key Global Diabetic Injection Pen Industry Players

• Astrazeneca Plc
• Becton, Dickinson and Company
• Biocon
• Eli Lilly and Company
• Merck & Company, Inc.
• Hoffmann-La Roche AG
• Jiangsu Delfu medical device Co., Ltd.
• Merck & Company, Inc.
• Novo Nordisk A/S
• Sanofi SA
• Wockhardt Ltd.